Health officials from CDC and the state of Texas are reeling in the wake of today's report that a second nurse at the Texas hospital that treated Ebola patient Thomas Eric Duncan has tested positive for the virus. The news came while health leaders were still trying to determine how 26-year-old nurse Nina Pham contracted Ebola while caring for the first patient diagnosed with the disease on US soil. Meanwhile, the largest nurses' union says its members report that most hospitals are not ready for an Ebola patient.
Health officials from CDC and the state of Texas are reeling in the wake of today’s report that a second nurse at the Texas hospital that treated Ebola patient Thomas Eric Duncan has tested positive for the virus. The news came while health leaders were still trying to determine how 26-year-old nurse Nina Pham contracted Ebola while caring for the first patient diagnosed with the disease on US soil.
Top public health officials grasped for answers as fears grow that most hospitals would fare no better than Texas Presbyterian if a patient exhibiting Ebola symptoms landed in their emergency room. Meanwhile, reports of suspected Ebola cases that turned out to be false alarms have started to crop up, including one from Mobile, Alabama.
In an extraordinary admission, CDC Director Thomas Frieden, MD, MPH, yesterday said that that the agency should have moved more quickly to assist Texas Presbyterian Hospital after Mr Duncan tested positive for Ebola, and said CDC would now send teams to enforce patient care protocols as soon as a diagnosis is made. Mr Duncan died on October 8, 2014, more than a week after he returned to Texas Presbyterian’s emergency department (ED) after his symptoms worsened; Texas Presbyterian officials have come under fire for sending Mr Duncan home with antibiotics when he first appeared in their ED.
“Getting it right is really, really important because the stakes are so high,” Dr Frieden said during a news conference. “We could have sent a more robust hospital infection control team and been more hands on with the hospital from Day One about how this should be managed.”
That was little comfort to the leaders of National Nurses United (NNU), who yesterday held a press conference to decry what they called sloppy conditions at Texas Presbyterian. The nurses issued updated results from a survey of 2300 members, who report that most hospitals are not prepared to treat a patient with Ebola.
“There is no standard short of optimal in protective equipment and hands-on-training that is acceptable,” said RoseAnn DeMoro, executive director of NNU, the largest US organization of nurses.
ABC News reported a union statement that Mr Duncan was left in a nonquarantined zone for hours, and a nurse supervisor faced resistance from hospital leaders after demanding that Mr Duncan be moved to an isolation unit. Additionally, Mr Duncan’s lab specimens were through the hospital’s tube system, potentially contaminating the system, the nurses said. In response, Texas Presbyterian issued a statement that numerous steps were taken to ensure patient and worker safety, including annual training and a hotline to anonymously report problems.
According to the NNU survey:
The extraordinary challenge that healthcare workers face in treating Ebola patients was highlighted further in CDC’s Mortality and Morbidity Weekly Report, which yesterday included a paper on an Ebola treatment unit within a hospital in Monrovia, Liberia. Over 2 weeks in July 2014, 5 healthcare workers contracted the virus, and 2 died, even though none of the workers reportedly had any known protocol violations that exposed them to the virus.
Around the Web
Second Health Care Worker Tests Positive for Ebola at Dallas Hospital
CDC Should Have Been More Hands On With Dallas Ebola Case, Director Says
National Conference Call for Nurses on Ebola
Cluster of Ebola Cases Among Liberian and US Healthcare Workers: MMWR
NCCN Guidelines Update Adds Momelotinib Below Ruxolitinib for High-, Low-Risk Myelofibrosis
January 23rd 2024Momelotinib was given category 2A and 2B status for patients with high- and low-risk myelofibrosis (MF) and MF with anemia. However, ruxolitinib retains a higher category of recommendation as a treatment for patients with MF.
Read More
Oncology Onward: A Conversation With Dr Shereef Elnahal, Under Secretary for Health
April 20th 2023Shereef Elnahal, MD, MBA, under secretary for health at the Veterans Health Administration (VHA), sat for a conversation with our hosts Emeline Aviki, MD, MBA, Memorial Sloan Kettering Cancer Center, and Stephen Schleicher, MD, MBA, Tennessee Oncology, that covered the cancer footprint of the VHA.
Listen
Interventions Needed to Increase DMT Uptake in Sickle Cell Disease
December 26th 2023A recent study found that uptake of disease-modifying therapies (DMTs) has been low among patients with sickle cell disease, suggesting that more interventions that consider individual patient characteristics are needed to improve adoption.
Read More
Exploring Payer Coverage Decisions Following FDA Novel Drug Approvals
May 3rd 2022On this episode of Managed Care Cast, Ari D. Panzer, BS, lead author and researcher, then at Tufts Medical Center—now at Duke University—discusses the findings from his team’s investigation into coverage decisions by health plan insurers of the 66 drugs approved by the FDA in 2018.
Listen
Exagamglogene Autotemcel Meets End Points in Severe Sickle Cell Disease, β-Thalassemia
December 7th 2023Two posters set to be presented at the 65th American Society of Hematology Annual Meeting & Exposition met their primary and secondary end points regarding exagamglogene autotemcel therapy for sickle cell disease and β-thalassemia.
Read More